C-17: Cardiovascular consequences of sleep apnea: What is new?
-
Register
- Non-member - $50
- Regular Member - $50
- Student Member - $50
- Technician Member - $50
This course was presented in person at World Sleep 2025 in Singapore.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the course by navigating to the timestamp indicated below.
0:00:00
Sleep apnea in hypertrophic cardiomyopathy: Prevalence, pathophysiology and prognostic implications
Virend Somers (United States)
0:36:20
Sleep apnea and heart failure
Douglas Bradley (Canada)
1:30:50
Long-term cardiovascular outcomes of sleep apnea: From childhood to adulthood
Kate Chan (Hong Kong)
2:15:05
Mandibular advancement versus CPAP for blood pressure control in patients with hypertension and cardiovascular risk
Ronald Lee (Singapore)
2:56:20
Tirzepatide and cardiovascular outcomes: implications for sleep apnea management
Atul Malhotra (United States)
Course Summary:
This course delves into the latest research and clinical insights on the cardiovascular implications of sleep apnea. It features a series of expert talks that cover a range of topics, from the pathophysiology of sleep apnea in specific conditions to the long-term cardiovascular outcomes and management strategies.
Learning objectives:
Upon completion of this activity, participants should be able to:
• Identify the prevalence and subtypes of sleep apnea in patients with hypertrophic cardiomyopathy and analyze the relationships between sleep apnea and excessive daytime sleepiness, troponins, and major adverse cardiovascular events
• Examine the relationship between sleep apnea and heart failure
• Evaluate the long-term cardiovascular outcomes of sleep apnea from childhood through adulthood
• Recognize the potential and effectiveness of obstructive sleep apnea (OSA) treatment using mandibular advancement devices in optimizing blood pressure and improving sleep-related and general quality-of-life measures
• Assess the potential impact of Tirzepatide on cardiovascular outcomes and its implications for the management of sleep apnea, offering new perspectives on treatment options